← Open Payments lookup

STEVEN GIBSON: Open Payments

NPI 1336146422 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,131 in 50 payments from 8 companies in 2025. Trend: 2023 $891 · 2024 $973 · 2025 $1,131

Food & beverage: $1,131
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$370
Otsuka America Pharmaceutical, Inc.11$227
Lundbeck LLC9$183
Alkermes, Inc.7$140
Teva Pharmaceuticals USA, Inc.4$102
E.R. Squibb & Sons, L.L.C.3$69
Janssen Pharmaceuticals, Inc1$27
Luye Pharma (USA) Ltd.1$14

Products named: ABILIFY ASIMTUFII, INGREZZA, ARISTADA, UZEDY, COBENFY, SPRAVATO, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE.

Industry payments across IN — which companies pay providers there.